Literature DB >> 20599974

Lack of neuroprotective effects of simvastatin and minocycline in a model of cervical spinal cord injury.

Jae H T Lee1, Seth Tigchelaar, Jie Liu, Anthea M T Stammers, Femke Streijger, Wolfram Tetzlaff, Brian K Kwon.   

Abstract

Minocycline, a commonly prescribed tetracycline antibiotic, has shown promise as a potential therapeutic agent in animal models of numerous neurologic disorders such as amyotrophic lateral sclerosis, multiple sclerosis, Parkinson's disease, Huntington's disease, stroke, and spinal cord injury (SCI). Simvastatin is one of many hydroxymethylglutaryl-coenzyme-A reductase inhibitors prescribed to lower cholesterol. These drugs are also known to reduce inflammation and oxidative stress, improve endothelial function, and modulate the immune system in stroke, traumatic brain injury, and SCI. As both drugs have translational potential, we evaluated their neuroprotective properties here in a clinically relevant model of contusive cervical spinal cord injury. Sprague-Dawley rats underwent a unilateral cervical contusion SCI at C5 and were randomized to receive: 1. Minocycline 90 mg/kg x 3 days, 2. Simvastatin 20 mg/kg x 7 days, 3. Simvastatin 20 mg/kg x 7 days then 5mg/kg x 35 days, or 4. Saline (Control). Behavioral recovery was assessed over 6 weeks using the horizontal ladder test, cylinder rearing test, modified Montoya staircase test and grooming test. Forepaw sensitivity was also assessed using the electronic von Frey Aesthesiometer. The corticospinal and rubrospinal tracts were traced and the spinal cords were harvested 7 weeks after injury. The extent of gray matter and white matter sparing and corticospinal and rubrospinal tract sprouting were evaluated in cross sections of the spinal cord. In the end, neither minocycline nor simvastatin treatment was associated with improved performance on the behavioral tests, as compared to saline controls. Performance on the horizontal ladder test, cylinder rearing test, and von Frey sensory test were similar among all groups. Animals treated for 42 days with simvastatin scored significantly higher in the grooming score compared to other groups, but retrieved significantly fewer pellets on the modified Montoya staircase test than control and minocycline treated animals. Histologically, there were no significant differences in white and gray matter sparing and in the extent of corticospinal and rubrospinal sprouting between the four groups. In conclusion, both minocycline and simvastatin failed to improve functional and histological recovery in our model of contusive cervical spinal cord injury. Copyright 2010 Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20599974     DOI: 10.1016/j.expneurol.2010.06.018

Source DB:  PubMed          Journal:  Exp Neurol        ISSN: 0014-4886            Impact factor:   5.330


  21 in total

1.  Macrophage Transcriptional Profile Identifies Lipid Catabolic Pathways That Can Be Therapeutically Targeted after Spinal Cord Injury.

Authors:  Y Zhu; K Lyapichev; D H Lee; D Motti; N M Ferraro; Y Zhang; S Yahn; C Soderblom; J Zha; J R Bethea; K L Spiller; V P Lemmon; J K Lee
Journal:  J Neurosci       Date:  2017-01-27       Impact factor: 6.167

2.  A contusive model of unilateral cervical spinal cord injury using the infinite horizon impactor.

Authors:  Jae H T Lee; Femke Streijger; Seth Tigchelaar; Michael Maloon; Jie Liu; Wolfram Tetzlaff; Brian K Kwon
Journal:  J Vis Exp       Date:  2012-07-24       Impact factor: 1.355

Review 3.  Behavioral testing in animal models of spinal cord injury.

Authors:  K Fouad; C Ng; D M Basso
Journal:  Exp Neurol       Date:  2020-07-28       Impact factor: 5.330

Review 4.  Translational spinal cord injury research: preclinical guidelines and challenges.

Authors:  Paul J Reier; Michael A Lane; Edward D Hall; Y D Teng; Dena R Howland
Journal:  Handb Clin Neurol       Date:  2012

5.  Human iPS cell-derived astrocyte transplants preserve respiratory function after spinal cord injury.

Authors:  Ke Li; Elham Javed; Daniel Scura; Tamara J Hala; Suneil Seetharam; Aditi Falnikar; Jean-Philippe Richard; Ashley Chorath; Nicholas J Maragakis; Megan C Wright; Angelo C Lepore
Journal:  Exp Neurol       Date:  2015-07-26       Impact factor: 5.330

6.  Chronic at-level thermal hyperalgesia following rat cervical contusion spinal cord injury is accompanied by neuronal and astrocyte activation and loss of the astrocyte glutamate transporter, GLT1, in superficial dorsal horn.

Authors:  Rajarshi Putatunda; Tamara J Hala; Jeannie Chin; Angelo C Lepore
Journal:  Brain Res       Date:  2014-05-14       Impact factor: 3.252

Review 7.  The animal model of spinal cord injury as an experimental pain model.

Authors:  Aya Nakae; Kunihiro Nakai; Kenji Yano; Ko Hosokawa; Masahiko Shibata; Takashi Mashimo
Journal:  J Biomed Biotechnol       Date:  2011-03-07

8.  Activated microglia inhibit axonal growth through RGMa.

Authors:  Mari Kitayama; Masaki Ueno; Toru Itakura; Toshihide Yamashita
Journal:  PLoS One       Date:  2011-09-21       Impact factor: 3.240

9.  Acute minocycline treatment mitigates the symptoms of mild blast-induced traumatic brain injury.

Authors:  Erzsebet Kovesdi; Alaa Kamnaksh; Daniel Wingo; Farid Ahmed; Neil E Grunberg; Joseph B Long; Christine E Kasper; Denes V Agoston
Journal:  Front Neurol       Date:  2012-07-16       Impact factor: 4.003

10.  Beyond the lesion site: minocycline augments inflammation and anxiety-like behavior following SCI in rats through action on the gut microbiota.

Authors:  Emma K A Schmidt; Pamela J F Raposo; Abel Torres-Espin; Keith K Fenrich; Karim Fouad
Journal:  J Neuroinflammation       Date:  2021-06-26       Impact factor: 8.322

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.